MedTrace Logo

The Influence of Manual and Verbal Guidance for Therapeutic Results in People With Parkinson's Disease

NCT03774225 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2019-02-18

No results posted yet for this study

Summary

A prospective, single-blind, parallel-group, randomised trial was conducted in Sao Paulo, Brazil. Thrid eight People with Parkinson's Disease were recruited and randomly allocated in two groups: Experimental Group (EG), that performed the balance and gait training based on games from Microsoft Xbox Kinect System ® (MXKS) supported by manual and verbal guidance (MVG) provided by a PT and a control group (CG) that performed an identical training with no MVG during the training.

Conditions

  • Parkinson Disease

Interventions

OTHER

Virtual Reality with Manual and Verbal Guidance

Participants will perform 4 balance games during 8 sessions with a manually and verbally assisted by a experient physiotherapist.

OTHER

Virtual Reality with No Manual and Verbal Guidance

Participants will perform 4 balance games during 8 sessions in the presence of a experient physiotherapist that will ensure patient safety, providing motivational verbal stimuli, and replicating the feedback provided by the game.

OTHER

Physical Therapy

Patients of the control group will be trained with balance exercises by a experient physiotherapist.

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Maria Elisa P Piemonte · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-04-30
Completion
2019-07-20

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03774225 on ClinicalTrials.gov